Whether mapping the human genome, cultivating the epicenter of cybersecurity, engineering solutions for global climate change, or manufacturing critical components for the unmanned, autonomous and sensor community, companies in Maryland excel. Now, let us show you why Maryland is the right choice for you.
Emergent BioSolutions Signs $53 Million Modification to BARDA Contract for the Manufacture of Botulism Antitoxin
GAITHERSBURG, Md., March 31, 2017 (GLOBE NEWSWIRE) — Emergent BioSolutions Inc. (NYSE:EBS) today announced that it has signed a modification to its contract with the Biomedical Advanced Research and Development Authority (BARDA) to manufacture and store bulk drug substance for its botulism antitoxin, BAT® [Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G) – (Equine)], valued at approximately $53 million with a five-year period of performance. This modification to the contract will enable future filling and deliveries of final drug product to the Strategic National Stockpile (SNS). BAT is indicated for the treatment of symptomatic botulism following documented or suspected exposure to botulinum neurotoxin serotypes A, B, C, D, E, F, or G in adults and pediatric patients.
“Emergent is proud to be a longstanding partner to the U.S. government in providing first-in-class and only-in-class products that address biological threat agents,” said Adam Havey, executive vice president, business operations at Emergent BioSolutions. “This modification to the contract represents the U.S. government’s continued commitment to developing critical countermeasures such as BAT that address public health threats and fulfill its preparedness needs.”
Emergent has been supplying BAT to the SNS under contract HHSO100200600017C, which was signed in 2006 with BARDA, within the Office of the Assistant Secretary for Preparedness and Response, in the U.S. Department of Health and Human Services. BAT is the only botulism antitoxin licensed by the U.S. Food and Drug Administration and distributed from the Centers for Disease Control and Prevention for treating naturally occurring, non-infant botulism, and for administration under emergency conditions.
About Emergent BioSolutions
Emergent BioSolutions Inc. is a global life sciences company seeking to protect and enhance life by focusing on providing specialty products for civilian and military populations that address accidental, intentional, and naturally emerging public health threats. Through our work, we envision protecting and enhancing 50 million lives with our products by 2025. Additional information about the company may be found at emergentbiosolutions.com. Follow us @emergentbiosolu.
Whether mapping the human genome, cultivating the epicenter of cybersecurity, engineering solutions for global climate change, or manufacturing critical components for the unmanned, autonomous and sensor community, companies in Maryland excel. Now, let us show you why Maryland is the right choice for you.
The Economic Alliance of Greater Baltimore (EAGB) is a not-for-profit economic development organization led by a partnership of regional business executives, elected government officials and leaders from higher education, focused on fostering business retention and development, job creation and new investment throughout the Greater Baltimore region.
The Montgomery County Economic Development Corporation (MCEDC) brings a big and bold approach to achieving greater economic competitiveness and prosperity across Montgomery County, MD.
A nonprofit organization with a fresh public/private perspective, entrepreneurial spirit, and proactive approach to economic development, the MCEDC is focused on maximizing Montgomery County’s rich diversity of people, talent, and multitude of workforce and business expertise to keep it at the leading edge of today’s hyper-competitive economic development environment.
Comprised of a highly-inclusive team of 11 on its Board of Directors, the MCEDC is committed to upholding and extending the County’s vibrant community and leveraging the advantages it brings for the future of business across the region.
The Secretary of Commerce and Trade oversees the economic, community, and workforce development of the Commonwealth. Each of the 13 Commerce and Trade Agencies actively contributes to Virginia’s economic health and high quality of life.
The Commonwealth of Virginia was founded as a business venture more than 400 years ago, and is blessed with many assets, including, but not limited to:
The primary job of the Secretariat of Commerce and Trade is to make sure we utilize these assets to help Virginia sustain its position as the preeminent place to live, work and conduct business.
GlaxoSmithKline and Regeneron have given their backing to a new project that will use patient data held by the UK Biobank.
The firms will get free access to the samples in return for covering the cost of sequencing it and, after a period of exclusivity, they will then allow the data to be plugged back into the resource for wider use.
The Biobank said the initiative would be the biggest ever genetics study and could usher in a “new era of drug development”.
The University System of Maryland announced this month the launch of its Maryland Momentum Fund, which will provide $25 million to support startups formed within the system.
The university system has already committed $10 million to the initiative, and is working alongside the University of Maryland, Baltimore County as well as UM Ventures — a joint research and innovation program between this university and the University of Maryland, Baltimore — to obtain the remaining $15 million from local venture capitalists and angel investors, said Julie Lenzer, UM Ventures co-director.
